Exempa Lin Met XR 10/5/1000mg Tablet — Triple Therapy for Type 2 Diabetes
Pay in 3 Installments of
Rs.
171
JazzCash
easypaisa
NayaPay
Bank transfer
Cash on Delivery
Description
Exempa Lin Met XR 10/5/1000mg Tablet is a fixed-dose triple combination containing Empagliflozin 10mg (SGLT2 inhibitor), Linagliptin 5mg (DPP-4 inhibitor), and Metformin HCl 1000mg XR (biguanide) — prescribed for adults with Type 2 Diabetes Mellitus requiring intensified glycaemic management from triple complementary mechanisms in one extended-release tablet.
Empagliflozin 10mg lowers blood glucose via urinary glucose excretion and provides cardiovascular and renal cardioprotection. Linagliptin 5mg delivers the full clinical dose of DPP-4 inhibition, enhancing insulin secretion and reducing glucagon. Metformin XR 1000mg reduces hepatic glucose output and improves insulin sensitivity with extended tolerability profile.
For higher Empagliflozin dosing (12.5mg), consider Exempa Lin Met XR 12.5/2.5/1000mg Tablet. For dual SGLT2+Metformin therapy, see Empaglimet 12.5/500mg Tablet.
Safety Information: Not for Type 1 diabetes or diabetic ketoacidosis. Contraindicated in severe renal impairment (eGFR <45). Monitor kidney function and blood glucose regularly. Rx only — valid prescription required. Email to sales@derma.pk or WhatsApp +92-320-5999650.
Usage & Benefits
- Triple-mechanism blood glucose control: SGLT2 + DPP-4 + biguanide
- Full clinical dose of Linagliptin 5mg for maximum DPP-4 inhibition
- Empagliflozin 10mg provides proven cardiovascular and renal benefits
- Extended-release Metformin 1000mg reduces GI side effects vs immediate-release
- Convenient once-daily fixed-dose combination reducing tablet burden
How To Use
1. Take Exempa Lin Met XR 10/5/1000mg once daily as prescribed by your doctor.
2. Swallow the tablet whole with a glass of water — do not crush, cut, or chew.
3. Take with the evening meal to reduce gastrointestinal side effects.
4. Monitor blood glucose and kidney function (eGFR) regularly during therapy.
5. Do not stop or reduce the dose without consulting your physician.
6. Use only as directed by your healthcare provider.
FAQs
How does Exempa Lin Met XR 10/5/1000mg differ from the 12.5/2.5 version?
The 10/5/1000mg variant contains Empagliflozin 10mg and Linagliptin 5mg (full DPP-4 inhibitor dose), while the 12.5/2.5/1000mg contains Empagliflozin 12.5mg and Linagliptin 2.5mg. Your doctor will choose the formulation based on your individual dose requirements.
Is Exempa Lin Met XR suitable for elderly patients?
Older patients with reduced kidney function require dose assessment. As eGFR can decline with age, kidney function must be evaluated by your doctor before prescribing and during treatment.
Will this medicine cause weight loss?
The Empagliflozin component may result in modest weight reduction due to urinary glucose and calorie excretion. This is a clinically observed benefit, not a primary indication.
